MedTrace Logo

Imaging Progression of Chronic Obstructive Pulmonary Disease Using MRI and CT (MR-COPDII)

NCT03591562 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 252

Last updated 2024-05-24

No results posted yet for this study

Summary

In this follow-up trial, MRI and CT images of the lung will be acquired prospectively in a subcohort of 370 patients, three years after they successfully participated in the first COSYCONET subtrial with CT and MRI ("MR-COPD I", NCT (clinical.Trials.gov identifier) 02629432).

The objective is to obtain longitudinal data from a well-characterized collective of COPD patients in order to identify suitable image-based biomarkers to improve the prognosis of disease progression of COPD in comparison to clinical tests

Conditions

Sponsors & Collaborators

  • Philipps University Marburg

    collaborator OTHER

  • Hannover Medical School

    collaborator OTHER

  • German Center for Lung Research

    collaborator OTHER

  • University Hospital Heidelberg

    lead OTHER

Principal Investigators

  • Juergen Biederer, Prof · University Hosital Heidelberg

  • Bertram J. Jobst, MD · University Hospital Heidelberg

Eligibility

Min Age
40 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-10
Primary Completion
2019-12-31
Completion
2024-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03591562 on ClinicalTrials.gov